Diageo plc (GUI)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 21.35 |
|---|---|
| 52-week range | 15.65 – 21.90 |
| Return, 1 month / 3 months | +14.7% / +19.8% |
| Return, 1 year / 3 years | +4.1% / −34.4% |
| Trend | Uptrend |
| RSI (14) | 74 |
| Volatility (1 year) | 32.1% |
| Worst drawdown (1 year) | -27.1% |
| Average daily value traded | 0.99M EUR |
| Dividend yield | 2.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Diageo is a drinks company based in London that makes and markets spirits, beer and wine. Its portfolio includes Scotch whisky, vodka, gin, rum and tequila brands alongside stout and other beers. The company serves retailers, bars, restaurants and distributors in many countries, and its products reach consumers through shops and licensed premises across the globe. It also produces ready-to-drink beverages and some wine.
The shares are listed on the XETRA Stock Exchange in Germany under the code GUI, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Diageo plc (GUI) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 21.35 on 23 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a fair price profile), ranking 109 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 4.1% and over the last three months it rose 19.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 84 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 17.0% | ||
| From 52-week high | -1.2% | ||
| Momentum | 72 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 19.8% | ||
| 6-month return | 27.2% | ||
| 12-month return, skipping the last month | -9.2% | ||
| Stability (higher is calmer) | 61 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 32.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.1% | ||
| Liquidity | 72 · Strong | Trades actively. | |
| Average daily value traded | 0.99M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 50 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.5% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.7% |
|---|---|
| 1 month | +14.7% |
| 3 months | +19.8% |
| 6 months | +27.2% |
| 1 year | +4.1% |
| 3 years | −34.4% |
| 5 years | −43.0% |
Signals
| 50-day / 200-day average | 19.35 / 18.24 |
|---|---|
| Golden / death cross (60 days) | Golden, 51 days ago |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.42 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Oct 2026 | GBP 0.2669 |
| 16 Apr 2026 | GBP 0.1779 |
| 16 Oct 2025 | GBP 0.5679 |
| 27 Feb 2025 | GBP 0.3732 |
| 29 Aug 2024 | GBP 0.5599 |
| 29 Feb 2024 | GBP 0.3799 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.